Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment trial
暂无分享,去创建一个
E. Soliman | D. Duprez | J. Stein | D. Wohl | G. Tambussi | Shweta Sharma | K. Arastéh | A. Phillips | Amit C. Achhra | J. O'Connor | D. James | Neaton
[1] D. Duprez,et al. Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation , 2014, Journal of the American Heart Association.
[2] R. Paredes,et al. Adjudicated Morbidity and Mortality Outcomes by Age among Individuals with HIV Infection on Suppressive Antiretroviral Therapy , 2014, PloS one.
[3] M. Law,et al. Relationship between CD4 cell count and serious long-term complications among HIV-positive individuals , 2014, Current opinion in HIV and AIDS.
[4] A. Phillips,et al. Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study , 2013, Clinical trials.
[5] D. Costagliola,et al. HIV and coronary heart disease: time for a better understanding. , 2013, Journal of the American College of Cardiology.
[6] E. Soliman,et al. Prevalence and prognostic significance of ECG abnormalities in HIV-infected patients: results from the Strategies for Management of Antiretroviral Therapy study. , 2011, Journal of electrocardiology.
[7] O. Kirk,et al. Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.
[8] D. Jacobs,et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. , 2010, The Journal of infectious diseases.
[9] M. Dubé,et al. Inflammation and complications of HIV disease. , 2010, The Journal of infectious diseases.
[10] D. Costagliola,et al. No evidence for a polyomavirus association or aetiology in AIDS-associated nonsmall cell lung cancer , 2010, AIDS.
[11] S. Grinspoon. Diabetes mellitus, cardiovascular risk, and HIV disease. , 2009, Circulation.
[12] P. Morlat,et al. Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic) , 2008, Journal of acquired immune deficiency syndromes.
[13] P. Wilson,et al. Initiative to Decrease Cardiovascular Risk and Increase Quality of Care for Patients Living With HIV/AIDS Executive Summary , 2008 .
[14] J. Meigs,et al. Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors. , 2008, Circulation.
[15] M. Pencina,et al. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.
[16] Hang Lee,et al. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. , 2007, The Journal of clinical endocrinology and metabolism.
[17] O. Kirk,et al. Class of antiretroviral drugs and the risk of myocardial infarction. , 2007, The New England journal of medicine.
[18] Mark R Wallace,et al. Comparisons of Causes of Death and Mortality Rates Among HIV-Infected Persons: Analysis of the Pre-, Early, and Late HAART (Highly Active Antiretroviral Therapy) Eras , 2006, Journal of acquired immune deficiency syndromes.
[19] P. Morlat,et al. Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. , 2004, International journal of epidemiology.
[20] Rodolphe Thiébaut,et al. Combination antiretroviral therapy and the risk of myocardial infarction , 2003 .
[21] A. Dyer,et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. , 2003, JAMA.
[22] A. Dyer,et al. Major Risk Factors as Antecedents of Fatal and Nonfatal Coronary Heart Disease Events , 2003 .
[23] Anne L. Taylor,et al. Coronary heart disease in HIV-infected individuals. , 2003, Journal of acquired immune deficiency syndromes.
[24] D. Arveiler,et al. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[25] T. Louis,et al. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. , 2003, The New England journal of medicine.
[26] LOW RISK-FACTOR PROFILE AND LONG-TERM CARDIOVASCULAR AND NON-CARDIOVASCULAR MORTALITY AND LIFE EXPECTANCY , 2000 .
[27] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[28] A. Marty. Minnesota Code Manual of Electrocardiographic Findings , 1983 .